Evidence map›Paper›PMID 29856983›Full record

ArticleExperimental and molecular pathology2018

Soft agar-based selection of spontaneously transformed rat prostate epithelial cells with highly tumorigenic characteristics.

Martina Šrajer Gajdošik, Douglas C Hixson, Kate E Brilliant, DongQin Yang, Monique E De Paepe, Djuro Josić, David R Mills

Open access · greenAbstract read
In one paragraph

Article in Experimental and molecular pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Martina Šrajer GajdošikDepartment of Chemistry, University of J.J. Strossmayer of Osijek, Cara Hadrijana 8/A, HR-31000 Osijek, Croatia; Division of Hematology and Oncology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA. Electronic address: msgajdosik@kemija.unios.hr.
Douglas C HixsonDivision of Hematology and Oncology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA; The Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA.
Kate E BrilliantDivision of Hematology and Oncology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.
DongQin YangDivision of Hematology and Oncology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.
Monique E De PaepeThe Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA; Department of Pathology, Women and Infants Hospital, 101 Dudley St, Providence, RI 02905, USA.
Djuro JosićThe Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA; Department of Biotechnology, University of Rijeka, Radmile Matejčić 2, HR-51000 Rijeka, Croatia.
David R MillsDivision of Hematology and Oncology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA; The Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA. Electronic address: dmille15@providence.edu.
Rhode Island Hospital · USBrown University · USProvidence College · USUniversity of Rijeka · HR

Funding

UCP2 expression in colon cancerP20RR017695 · NCRR · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI CHATTERJEE, DEVASIS · 2002 to 2011
$15.0M
COBRE Center for Cancer Research DevelopmentP30GM110759 · NIGMS · RHODE ISLAND HOSPITAL · PI GRUPPUSO, PHILIP A. · 2015 to 2019
$6.3M
COBRE Center for Cancer Research DevelopmentP20GM103421 · NIGMS · RHODE ISLAND HOSPITAL · PI RAMRATNAM, BHARAT · 2012 to 2013
$4.5M
Genesis of Liver Carcinomas with Oval Cell TraitsR01CA093840 · NCI · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI MILLS, DAVID · 2002 to 2011
$3.1M
CELLULAR ORIGINS OF LIVER CANCERR01CA042715 · NCI · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI HIXSON, DOUGLAS CARTER · 1985 to 2008
$2.3M
NCI NIH HHS R01 CA042715NCI NIH HHS R01 CA093840NCRR NIH HHS P20 RR017695NIGMS NIH HHS P20 GM103421NIGMS NIH HHS P30 GM110759
6 · The paper itself

Abstract

The critical molecular and cellular mechanisms involved in the development and progression of prostate cancer remain elusive. In this report, we demonstrate that normal rat prostate epithelial cells (PEC) undergo spontaneous transformation at high passage (p > 85) evidenced by the acquisition of anchorage independent growth when plated on soft agar and tumorigenicity when injected into immunodeficient mice. In addition, we also report the discovery of a minor subpopulation of spontaneously transformed PEC derived from high passage PEC with the ability to migrate through a layer of 1% agar and form expanding colonies on the underlying plastic substratum. Comparison of these soft agar invasive (SAI) cells with low (p < 35), mid (p36-84) and high passage (p > 85) PEC identified marked differences in cell morphology, proliferation and motility. The SAI subpopulation was more tumorigenic than the high passage anchorage independent cultures from which they were isolated, as manifested by a decreased latency period and an increase in the size of tumors arising in immunodeficient mice. In contrast, low and mid passage cells were unable to grow on soft agar and failed to form tumors when injected into immunodeficient mice. Screening with antibody-based signaling arrays identified several differences in the altered expression levels of signaling proteins between SAI-derived cells and low or high passage PEC, including the up-regulation of EGFR and MAPK-related signaling pathways in SAI-selected cells. In summary, these studies suggest that the SAI assay selects for a novel, highly tumorigenic subpopulation of transformed cells that may represent an early step in the progression of slow growing prostatic carcinomas into more rapidly growing and aggressive tumors.

Indexed as

Cell Transformation, NeoplasticAnimalsCell MovementCells, CulturedCell SeparationEpithelial CellsErbB ReceptorsMaleMAP Kinase Signaling SystemNeoplastic Stem CellsPrimary Cell CultureProstateRatsErbB ReceptorsCancer stem cellNeoplastic conversionProstate epithelial cellsTumorigenicity

Identifiers

PMID29856983
PMCPMC6071870
OpenAlexW2806529243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.